1022-45-3 Structure-based drug design: Synthesis and biological evaluation of quinazolin-4-amine derivatives as selective Aurora A kinase inhibitors

-
Aurora kinases play critical roles in the regulation of the cell cycle and mitotic spindle assembly. Aurora A kinase, a member of the Aurora protein family, is frequently highly expressed in tumors, and selective Aurora A inhibition serves as a significant component of anticancer therapy. However, designing highly selective Aurora A inhibitors is difficult because Aurora A and B share high homology and differ only by three residues in their ATP-binding pockets. Through structure-based drug design, we designed and synthesized a series of novel quinazolin-4-amine derivatives. These derivatives act as selective Aurora A kinase inhibitors by exploiting the structural differences between Aurora A and B. The selectivities of most compounds were improved (the best up to >757-fold) when comparing with the lead compound (3-fold). In vitro biochemical and cellular assays revealed that compound 6 potently inhibited Aurora A kinase and most human tumor cells. Furthermore, compound 6 effectively suppressed carcinoma, such as triple-negative breast cancers (TNBC) in an animal model. Therefore, compound 6 might serve as a promising anticancer drug. Moreover, through molecular dynamic (MD) analysis, we have identified that a salt bridge formed in Aurora B is key contributor for the isoform selectivity of the inhibitor. This salt bridge has not been previously detected in the reported crystal structure of Aurora B. These results might provide a crucial basis for the further development of highly potent inhibitors with high selectivity for Aurora A. https://www.lookchem.com/CASDataBase_1022-45-3.htm

评论

发表评论

此博客中的热门博文

1023-17-2 Syntheses, structures, and catalytic activity in Friedel–Crafts acylations of substituted tetramethylcyclopentadienyl molybdenum carbonyl complexes

-
Reactions of the substituted tetramethylcyclopentadienes [C 5 HMe 4 R] [R?=? t Bu, Ph, CH 2 CH 2 C(CH 3 ) 3 ] with Mo(CO) 3 (CH 3 CN) 3 in refluxing xylene gave a series of dinuclear molybdenum carbonyl complexes [(η 5 -C 5 Me 4 R)Mo(CO) 3 ] 2 [R?=? t Bu (1), Ph (2), CH 2 CH 2 C(CH 3 ) 3 (3)], [(η 5 -C 5 Me t Bu)Mo(μ-CO) 2 ] 2 (4)], and [(η 5 -C 5 Me 4 ) t Bu] 2 Mo 2 O 4 (μ-O) (5)], respectively. Complexes 1–5 were characterized by elemental analysis, IR, 1 H NMR, and 13 C NMR spectroscopy. In addition, their crystal structures were determined by X-ray crystal diffraction analysis. The catalytic activities of complexes 1–3 in Friedel–Crafts acylation in the presence of o-chloranil has also been investigated; the reactions were achieved under mild conditions to give the corresponding products in moderate yields. https://www.lookchem.com/CASDataBase_1023-17-2.htm
阅读全文

7440-47-3 Influence of pulse plating on the crystal structure and orientation of chromium

-
Chromium deposits with various structures and orientations were prepared by pulse plating from a sulfate-catalyzed chromic acid solution and without formic acid addition. The influences of the puls duration, off-time, curent density, formic acid concentration, and plating time on the structure and orientation were studied by X-Ray diffraction and transmition electron microcsopy. https://www.lookchem.com/CASDataBase_7440-47-3.htm
阅读全文

Competitive price of 1405-86-3 Top quality of Glycyrrhizic acid A exporter

-
图片
https://fujie.lookchem.com/ Why choose us 1.we are special in product  Glycyrrhizic Acid A  manufacturer 2.we have sufficient licorice quota every year. 3.We are only have  Glycyrrhizic Acid A GMP  certification in china. 4.Glycyrrhizic Acid A is CHINA name,another name is Glycyrrhizic Acid. Pionnier of Licorice Extract industry in China,  Shaanxi Fujie Pharmaceutical  co.,ltd has more than 25 years experience in the sector of licorice root extraction and provides high quality products to diverse industries. 
阅读全文